Literature DB >> 18757975

Middle-ear disease and schizophrenia: case-control study.

Peter Mason1, Michael Rimmer, Anna Richman, Gagan Garg, Joe Johnson, Patricia G Mottram.   

Abstract

BACKGROUND: One hundred years ago psychiatrists thought that ear disease could cause insanity by irritation of the brain. Current understanding of the role of the temporal lobes in schizophrenia and their proximity to the middle ear supports this hypothesis. AIMS: To establish the rate of middle-ear disease pre-dating the onset of schizophrenia.
METHOD: Eighty-four patients with schizophrenia were each matched to four non-psychiatric controls by age, gender and season of birth. History of ear disease was obtained from general practice records. Additional information on symptoms was collected for participants in the case group, who also had audiometry.
RESULTS: The odds ratio of recorded middle-ear disease pre-dating schizophrenia was 3.68 (95% CI 1.86-7.28). This excess was particularly marked on the left (OR=4.15, 95% CI 2.08-8.29). Auditory hallucinations were associated with middle-ear disease but not with hearing loss.
CONCLUSIONS: There is an association between middle-ear disease and schizophrenia which may have aetiological significance.

Entities:  

Mesh:

Year:  2008        PMID: 18757975     DOI: 10.1192/bjp.bp.108.052795

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

1.  Improvement in psychotic symptoms after a gluten-free diet in a boy with complex autoimmune illness.

Authors:  William W Eaton; Lian-Yu Chen; F Curtis Dohan; Deanna L Kelly; Nicola Cascella
Journal:  Am J Psychiatry       Date:  2015-03-01       Impact factor: 18.112

2.  Psychotic symptoms and sensory impairment: Findings from the 2014 adult psychiatric morbidity survey.

Authors:  Natalie Shoham; Gemma Lewis; Joseph Hayes; Sally McManus; Reza Kiani; Traolach Brugha; Paul Bebbington; Claudia Cooper
Journal:  Schizophr Res       Date:  2019-09-01       Impact factor: 4.662

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.